Core Laboratories Inc CLB.N reported quarterly adjusted earnings of 22 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 25 cents. The mean expectation of three analysts for the quarter was for earnings of 19 cents per share. Wall Street expected results to range from 19 cents to 20 cents per share.
Revenue rose 0.1% to $134.52 million from a year ago; analysts expected $131.30 million.
Core Laboratories Inc's reported EPS for the quarter was 30 cents.
The company reported quarterly net income of $14.24 million.
Core Laboratories Inc shares had fallen by 2.6% this quarter and lost 30.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 12.4% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the business support services peer group is "buy."
This summary was machine generated from LSEG data October 23 at 12:10 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2025 | 0.19 | 0.22 | Beat |
Jun. 30 2025 | 0.19 | 0.19 | Met |
Mar. 31 2025 | 0.15 | 0.14 | Missed |
Dec. 31 2024 | 0.22 | 0.22 | Met |
Comments